Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Masaya Koganesawa"'
Autor:
Kosuke Oikawa MD, PhD, Hirotaka Ochiai PhD, Kazuhiko Matsuhashi MD, PhD, Motoichiro Sakurai MD, PhD, Manabu Suzuki MD, PhD, Masaya Koganesawa MD, PhD, Tomomasa Terada MD, PhD, Yoko Ishii MD, Akatsuki Kokaze MD, PhD, Katsumi Mizuno MD, PhD
Publikováno v:
Global Pediatric Health, Vol 9 (2022)
In recent years, epidemics of respiratory syncytial virus (RSV) have been seen in the summer in Japan. Patients hospitalized in the summer used a high-flow oxygen administration device more frequently than patients hospitalized in the winter. This st
Externí odkaz:
https://doaj.org/article/fd5369fcae1e429da65ae7e6274efedf
Autor:
Sachio Fujita, Ryosuke Matsuno, Naoko Kawabata, Yumiko Sugishita, Ryota Kaneko, Masaya Koganesawa, Kosuke Akiyama, Daisuke Toyama, Shohei Yamamoto
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
Limited salvage chemotherapies are available for relapsed/refractory acute myeloid leukemia. Herein, we described successful reinduction chemotherapy, involving a combination of clofarabine, cyclophosphamide, and etoposide, in a 12-year-old male with
Externí odkaz:
https://doaj.org/article/3342733dd79b4cbea0b940d334859850
Autor:
Masaya Koganesawa, Ryosuke Matsuno, Yumiko Sugishita, Ryota Kaneko, Naoko Kawabata, Sachio Fujita, Kosuke Akiyama, Daisuke Toyama, Shohei Yamamoto
Publikováno v:
SAGE Open Medical Case Reports, Vol 9 (2021)
Pediatric acute lymphoblastic leukemia regimens include large L-asparaginase dosages and steroids, which are associated with an increased risk of venous thromboemboli in adolescents and young adults. Herein, we report the case of an 18-year-old male
Externí odkaz:
https://doaj.org/article/b4f56a0c6bd840a8a53cbce5f5135d35
Autor:
Daisuke Toyama, Ryosuke Matsuno, Yumiko Sugishita, Ryota Kaneko, Naoko Okamoto, Masaya Koganesawa, Sachio Fujita, Kosuke Akiyama, Keiichi Isoyama, Shohei Yamamoto
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Prognosis in pediatric patients with refractory/relapsed acute myeloid leukemia (AML) is grim, and there is no standard treatment for such patients. Combined treatment with intensive chemotherapy and gemtuzumab ozogamicin (GO), a monoclonal anti-CD33
Externí odkaz:
https://doaj.org/article/c556bb9ce40243518efca8636ccfa444
Publikováno v:
Biomolecules, Vol 11, Iss 1, p 25 (2020)
Macrophages activated by Interleukin (IL)-4 (M2) or LPS+ Interferon (IFN)γ (M1) perform specific functions respectively in type 2 inflammation and killing of pathogens. Group V phospholipase A2 (Pla2g5) is required for the development and functions
Externí odkaz:
https://doaj.org/article/54984aec09bf4059b231d133cf7368a9
Publikováno v:
The Tokai journal of experimental and clinical medicine. 47(3)
Granulocyte transfusions (GTX) have been used in patients with neutropenia or neutropenia associated with invasive fungal infection. An 11-year-old girl with severe aplastic anemia (SAA) received immunosuppressive therapy (IST) with rabbit antithymoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c0270dae699e8d2eaa0d26731d8b7de
https://pubmed.ncbi.nlm.nih.gov/36073285
https://pubmed.ncbi.nlm.nih.gov/36073285
Autor:
Satoru Ikezawa, Daisuke Toyama, Masaya Koganesawa, Yumiko Sugisita, Sachio Fujita, Kosuke Akiyama, Naoko Okamoto, Ryota Kaneko, Hirokazu Ikeda, Ryosuke Matsuno, Shohei Yamamoto, Yumi Hasegawa
Publikováno v:
The Showa University Journal of Medical Sciences. 32:25-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6510a9c35706de53c480a3d986a63518
https://doi.org/10.15369/sujms.32.25
https://doi.org/10.15369/sujms.32.25
Autor:
Yumiko Sugishita, Ryota Kaneko, Ryosuke Matsuno, Sachio Fujita, Masaya Koganesawa, Kosuke Akiyama, Naoko Kawabata, Shohei Yamamoto, Daisuke Toyama
Publikováno v:
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports, Vol 9 (2021)
SAGE Open Medical Case Reports, Vol 9 (2021)
Pediatric acute lymphoblastic leukemia regimens include large L-asparaginase dosages and steroids, which are associated with an increased risk of venous thromboemboli in adolescents and young adults. Herein, we report the case of an 18-year-old male
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4e5221a5bad317cc0be4ed2c9b09b7
http://europepmc.org/articles/PMC8114254
http://europepmc.org/articles/PMC8114254
Publikováno v:
Biomolecules
Volume 11
Issue 1
Biomolecules, Vol 11, Iss 25, p 25 (2021)
Volume 11
Issue 1
Biomolecules, Vol 11, Iss 25, p 25 (2021)
Macrophages activated by Interleukin (IL)-4 (M2) or LPS+ Interferon (IFN)&gamma
(M1) perform specific functions respectively in type 2 inflammation and killing of pathogens. Group V phospholipase A2 (Pla2g5) is required for the development and f
(M1) perform specific functions respectively in type 2 inflammation and killing of pathogens. Group V phospholipase A2 (Pla2g5) is required for the development and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e1b0da6c0531f5c5858ccf5668ca6b
Autor:
Keiichi Isoyama, Kosuke Akiyama, Naoko Okamoto, Ryota Kaneko, Sachio Fujita, Masaya Koganesawa, Yumiko Sugishita, Daisuke Toyama, Ryosuke Matsuno, Shohei Yamamoto
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Case Reports in Hematology
Case Reports in Hematology
Prognosis in pediatric patients with refractory/relapsed acute myeloid leukemia (AML) is grim, and there is no standard treatment for such patients. Combined treatment with intensive chemotherapy and gemtuzumab ozogamicin (GO), a monoclonal anti-CD33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9739c483792be5d3b0e8471280bbb6af
https://doaj.org/article/c556bb9ce40243518efca8636ccfa444
https://doaj.org/article/c556bb9ce40243518efca8636ccfa444